Hubei Zhongyi Science Technology Co., Ltd.
SZSE:301150.SZ
36.62 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,785.869 | 3,415.405 | 2,895.364 | 2,196.582 | 1,169.668 | 830.751 | 602.453 | 498.405 | 324.229 | 166.874 |
| Cost of Revenue
| 4,642.01 | 3,206.044 | 2,313.074 | 1,595.901 | 924.538 | 701.929 | 473.05 | 351.917 | 239.46 | 151.068 |
| Gross Profit
| 143.859 | 209.361 | 582.291 | 600.681 | 245.13 | 128.822 | 129.403 | 146.487 | 84.769 | 15.806 |
| Gross Profit Ratio
| 0.03 | 0.061 | 0.201 | 0.273 | 0.21 | 0.155 | 0.215 | 0.294 | 0.261 | 0.095 |
| Reseach & Development Expenses
| 171.203 | 134.573 | 108.609 | 80.875 | 45.992 | 31.432 | 23.584 | 17.781 | 0 | 0 |
| General & Administrative Expenses
| 12.152 | 8.578 | 7.008 | 8.713 | -47.47 | -56.181 | -43.46 | 36.318 | 22.389 | 15.242 |
| Selling & Marketing Expenses
| 4.551 | 5.051 | 10.06 | 8.713 | 6.087 | 14.228 | 10.479 | 6.485 | 4.915 | 2.513 |
| SG&A
| 16.703 | 13.62 | 17.068 | 17.427 | -41.383 | -41.953 | -32.981 | 42.803 | 27.304 | 17.755 |
| Other Expenses
| 44.122 | 22.399 | -0.451 | 24.991 | 147.259 | 119.2 | 74.315 | 4.779 | 0 | 0 |
| Operating Expenses
| 232.027 | 170.591 | 145.89 | 128.156 | 76.25 | 64.186 | 42.333 | 69.072 | 35.171 | 24.956 |
| Operating Income
| -88.168 | 38.77 | 449.897 | 435.413 | 141.002 | 43.941 | 75.015 | 71.992 | 54.655 | -2.585 |
| Operating Income Ratio
| -0.018 | 0.011 | 0.155 | 0.198 | 0.121 | 0.053 | 0.125 | 0.144 | 0.169 | -0.015 |
| Total Other Income Expenses Net
| -0.199 | -1.458 | -0.451 | -0.704 | -1.046 | -0.115 | -0.72 | 0.035 | 1 | 2.001 |
| Income Before Tax
| -88.368 | 37.312 | 449.446 | 434.709 | 139.956 | 43.826 | 74.295 | 72.027 | 49.598 | -9.066 |
| Income Before Tax Ratio
| -0.018 | 0.011 | 0.155 | 0.198 | 0.12 | 0.053 | 0.123 | 0.145 | 0.153 | -0.054 |
| Income Tax Expense
| -4.172 | -15.789 | 36.308 | 53.314 | 15.982 | 3.085 | 8.41 | 15.033 | 3.882 | 0.511 |
| Net Income
| -84.196 | 53.101 | 413.139 | 381.395 | 123.974 | 40.741 | 65.885 | 56.465 | 45.432 | -8.479 |
| Net Income Ratio
| -0.018 | 0.016 | 0.143 | 0.174 | 0.106 | 0.049 | 0.109 | 0.113 | 0.14 | -0.051 |
| EPS
| -0.47 | 0.29 | 3.43 | 2.9 | 0.94 | 0.31 | 0.74 | 0.69 | 1.14 | -0.21 |
| EPS Diluted
| -0.47 | 0.29 | 3.43 | 2.9 | 0.94 | 0.31 | 0.74 | 0.69 | 1.14 | -0.21 |
| EBITDA
| 63.421 | 152.196 | 526.343 | 473.91 | 191.412 | 84.814 | 104.527 | 89.519 | 68.743 | 10.858 |
| EBITDA Ratio
| 0.013 | 0.045 | 0.182 | 0.216 | 0.164 | 0.102 | 0.174 | 0.18 | 0.212 | 0.065 |